Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gag-p41 antigen is a cleavage product of the HIV-1 Gag polyprotein, comprised of the capsid protein (p24) and spacer peptide 1 (SP1). It is essential for virus assembly, maturation, and genome packaging. It is also a key target for maturation inhibitors and a common antigen used in HIV vaccine development due to its ability to elicit strong T cell responses. Mutations in the CA-SP1 region can lead to drug resistance.
Maturation inhibitors block cleavage of the Gag polyprotein at the CA-SP1 junction.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gag-p41 Antigen.